Results 31 to 40 of about 581,647 (319)
A brief overview of current drug repurposing approaches for COVID-19 management [PDF]
, 2020 This brief overview is intended to shed light on the current drug repositioning (also called drug repurposing) in the therapeutics of the novel coronavirus disease which emerged in 2019 (COVID-19).
Rodrigues, Pedro da Fonseca Soares +1 more
core +2 more sources
Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
Pathogens, 2020 Infection with severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) is a rapidly spreading and devastating global pandemic. Many researchers are attempting to clarify the mechanisms of infection and to develop a drug or vaccine against the virus,
Artur Słomka +2 more
doaj +1 more source
Repurposing Interleukin-6 Inhibitors to Combat COVID-19. [PDF]
, 2020 Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is a pandemic with major implications across the world. One of the most frequent causes of death from SARS-CoV-2 is fatal pneumonia from coronavirus disease 2019 (COVID-19), which is associated
Kato, Shumei, Kurzrock, Razelle
core +1 more source
Coronavirus disease 2019 (COVID-19) in Autoimmune Hepatitis
Hepatology Forum, 2022 Severe acute respiratory syndrome coronavirus 2 is a highly transmissible and pathogenic virus that leads to coronavirus disease 2019 (COVID-19). The preexisting liver diseases alter the course of COVID-19. Therefore, specific management strategies must be considered in individuals with chronic liver diseases (CLDs) and COVID-19.
Nur Dagli, Seyda, Efe, Cumali
openaire +2 more sources
Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications [PDF]
Journal of Cardiothoracic and Vascular Anesthesia, 2021 The coronavirus disease-2019 (COVID-19) has become a global pandemic. It has spread to more than 100 countries, and more than 1 million cases have been confirmed. Although coronavirus causes severe respiratory infections in humans, accumulating data have demonstrated cardiac complications and poor outcome in patients with COVID-19.
Ma, Lulu, Song, Kaicheng, Huang, Yuguang
openaire +2 more sources
Exploration, 2022 Coronavirus disease 2019 (COVID‐19) continually poses a significant threat to the human race, and prophylactic vaccination is the most potent approach to end this pandemic.
Ziqi Wang +3 more
doaj +1 more source
Medicine Science, 2020 COVID-19 (coronavirus disease 2019) is a viral infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and a World Health Organization (WHO) declared pandemic.
Monira Taha Ismail +1 more
doaj +1 more source
Pharmaceutical Sciences and Research, 2020 Coronavirus disease 2019 (COVID-19) is the disease caused by the highly transmittable novel coronavirus (SARS-CoV-2) infections. The disease was found at the end of December 2019, in Wuhan, China, and quickly spread worldwide with a higher mortality rate
Nuriza Ulul Azmi +2 more
doaj +1 more source
Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy [PDF]
Obstetric Anesthesia Digest, 2020 (Am J Obstet Gynecol. 2020;222:521–531) Caring for vulnerable populations is a critical component of pandemic management. Pregnant women are susceptible to respiratory illness with an increased infectious morbidity and mortality. While clinical information is limited on the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV ...
Dashraath, Pradip +8 more
openaire +3 more sources
Coronavirus disease 2019 (COVID-19) and QTc prolongation [PDF]
BMC Cardiovascular Disorders, 2021 Abstract Introduction The cause-and-effect relationship of QTc prolongation in Coronavirus disease 2019 (COVID-19) patients has not been studied well. Objective We attempt to better understand the relationship of QTc prolongation in COVID-19 patients in this study.
Khalid Changal +10 more
openaire +3 more sources